Transplant Oncology: A Frontier in Multidisciplinary Cancer Care
Editat de Maen A. Abdelrahimen Limba Engleză Paperback – 8 noi 2024
- Illustrates the concept and history of transplant oncology as an evolving field for the management of hepatocellular carcinoma
- Discusses the utility and safety of immunotherapy in the transplant setting
- Summarizes the utilization of immune checkpoint inhibitor therapies in pre-and post-liver transplants for HCC patients and discusses the assessment of immune checkpoint inhibitor regulators that might determine liver transplant outcomes
- Highlights new and evolving topics including the utilization of immunotherapy in special patient populations as well as the clinical updates on new concepts in the field, including treatment and rejection assessment
Preț: 800.01 lei
Preț vechi: 1050.66 lei
-24% Nou
Puncte Express: 1200
Preț estimativ în valută:
153.15€ • 159.20$ • 126.98£
153.15€ • 159.20$ • 126.98£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443219016
ISBN-10: 044321901X
Pagini: 360
Dimensiuni: 216 x 276 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 044321901X
Pagini: 360
Dimensiuni: 216 x 276 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
Section I: Transplant Oncology: An Evolving Field in Cancer Care 1. Transplant Oncology: concept, history, and evolution 2. Prehistory of Transplant Oncology Era Section II: Transplantations for Oncological Indications 3. Hepatocellular Carcinoma 4. Cholangiocarcinoma and liver transplantation 5. Transplantation for Oncological Indications: Colorectal Cancer Liver Metastases 6. Liver transplantation for neuroendocrine neoplasms liver metastases 7. Hepatoblastoma Section III: Transplant Oncology and Immunotherapy 8. Transplant Oncology and Immunotherapy: Immunotherapy and liver transplants 9. b. Immunotherapy and kidney transplant 10. Immunotherapy and Hematopoietic Stem Cell Transplantation 11. Immunotherapy in the Era of Transplant Oncology: Risks and Complications 12. Immunotherapy and immunosuppressants: Considerations in the clinical practice Section IV: Transplant Oncology and Precision Medicine 13. Molecular profiling and Next-Generation Sequencing applications in transplant oncology 14. Circulating tumor DNA (ctDNA) as a new and evolving tool in solid organ transplantation 15. Cell-free DNA (cfDNA) biomarkers for solid organ transplant rejection 16. Artificial intelligence in transplant Oncology Section V: Solid Organ Transplant and Cancers Considerations 17. De Novo malignancy Post Liver Transplantation: Recent Insights on Epidemiology and Surveillance Strategies 18. History of cancer and transplant clearance: Considerations prior to transplantation Section VI: Surgical Aspects of Transplant Oncology 19. Robotic Surgery for Liver Cancer and Applications in Liver Transplantation 20. Resection versus Transplantation for Intrahepatic and Hilar Cholangiocarcinoma 21. Liver transplantations for secondary cancers: surgical considerations 22. New strategies for two-stage hepatectomy 23. Living Donor Liver Transplantation 24. Patient characteristics and evaluations prior to liver transplantation 25. Challenges of liver transplantation for transplant oncology indications 26. Future of transplant oncology of the liver